CoreCap Advisors’s United Therapeutics UTHR Stock Holding History

CoreCap Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.1K	Sell	85 -56	-40%	-$31.5K	﹤0.01%	1443
2026 Q1	$83.6K	Buy	141 +124	+729%	+$61.8K	﹤0.01%	1097
2025 Q4	$8.28K	Sell	17 -8	-32%	-$3.73K	﹤0.01%	2028
2025 Q3	$10.5K	Buy	25 +2	+9%	+$673	﹤0.01%	1915
2025 Q2	$6.61K	Sell	23 -71	-76%	-$21.2K	﹤0.01%	2031
2025 Q1	$29K	Buy	94 +71	+309%	+$24.3K	﹤0.01%	1388
2024 Q4	$8.12K	Buy	23 +8	+53%	+$2.94K	﹤0.01%	1849
2024 Q3	$5.38K	Hold	15	–	–	﹤0.01%	1958
2024 Q2	$4.78K	Buy	+15	New	+$3.97K	﹤0.01%	1180

Other funds holding UTHR

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Ardsley Advisory Partners Stamford, Connecticut $921M AUM 207.76% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Augustine Asset Management Jacksonville, Florida $494M AUM 76.22% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

FCG Investment Company Germantown, Tennessee $289M AUM

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return